NCT05083793

Brief Summary

The effect of pregabalin on post-operative pain and opioid consumption in spine surgery, a prospective, randomized, controlled study

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for phase_2 postoperative-pain

Timeline
Completed

Started Apr 2020

Typical duration for phase_2 postoperative-pain

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2020

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

October 6, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

October 19, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2022

Completed
Last Updated

October 19, 2021

Status Verified

October 1, 2021

Enrollment Period

1.8 years

First QC Date

October 6, 2021

Last Update Submit

October 6, 2021

Conditions

Keywords

pregabalin

Outcome Measures

Primary Outcomes (1)

  • Morphia dose

    the total amount of rescue morphine received by patients for 24h postoperatively.

    24 hour postoperative

Secondary Outcomes (1)

  • Postoperative pain

    24 hour postoperative

Study Arms (2)

Study group

EXPERIMENTAL

patients have spine surgery receive oral pregabalin 150 mg 1 hour before surgery

Drug: Pregabalin 150mg

Placebo group

PLACEBO COMPARATOR

patients will receive placebo 1 hour before surgery with a sip of water.

Other: Placebo

Interventions

The effect of pregabalin on post-operative pain

Also known as: Pregabalin
Study group
PlaceboOTHER

patients will receive placebo one hour before operation

Placebo group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • : This prospective randomized clinical study will include eighty patients with ASA I-II, aged 18-60 years scheduled for spine surgery

You may not qualify if:

  • : Excluded from the study are patients with known allergy to the study drugs, significant cardiac, respiratory, renal, CNS or hepatic disease, drug or alcohol abuse, pregnant women, patients refusing participation and psychiatric or mental illness that would interfere with perception and assessment of pain.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mahmoud Maher

Asyut, 11174, Egypt

Location

Related Publications (3)

  • Ben-Menachem E. Pregabalin pharmacology and its relevance to clinical practice. Epilepsia. 2004;45 Suppl 6:13-8. doi: 10.1111/j.0013-9580.2004.455003.x.

    PMID: 15315511BACKGROUND
  • Hindmarch I, Trick L, Ridout F. A double-blind, placebo- and positive-internal-controlled (alprazolam) investigation of the cognitive and psychomotor profile of pregabalin in healthy volunteers. Psychopharmacology (Berl). 2005 Dec;183(2):133-43. doi: 10.1007/s00213-005-0172-7. Epub 2005 Nov 9.

    PMID: 16205916BACKGROUND
  • Sebastian B, Talikoti AT, Nelamangala K, Krishnamurthy D. Effect of Oral Pregabalin as Preemptive Analgesic in Patients Undergoing Lower Limb Orthopedic Surgeries under Spinal Anaesthesia. J Clin Diagn Res. 2016 Jul;10(7):UC01-4. doi: 10.7860/JCDR/2016/18854.8081. Epub 2016 Jul 1.

    PMID: 27630927BACKGROUND

Related Links

MeSH Terms

Conditions

Pain, Postoperative

Interventions

Pregabalin

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

gamma-Aminobutyric AcidAminobutyratesButyratesAcids, AcyclicCarboxylic AcidsOrganic ChemicalsAmino AcidsAmino Acids, Peptides, and Proteins

Study Officials

  • Mahmoud Maher, MD

    Assiut University Hospitals

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Masking Details
care provider
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of anesthesia and intensive care

Study Record Dates

First Submitted

October 6, 2021

First Posted

October 19, 2021

Study Start

April 1, 2020

Primary Completion

January 1, 2022

Study Completion

January 1, 2022

Last Updated

October 19, 2021

Record last verified: 2021-10

Data Sharing

IPD Sharing
Will share

make individual participant data (IPD) available to other researchers

Shared Documents
STUDY PROTOCOL
Time Frame
one year
Access Criteria
Study protocol
More information

Locations